Blood steroid hormone profile and clinical outcomes following switching from metyrapone to osilodrostat in patients with Cushing disease
Endocr J. 2025 Aug 29. doi: 10.1507/endocrj.EJ25-0089. Online ahead of print. ABSTRACT Steroidogenesis inhibitors such as metyrapone and osilodrostat, target […]
